|
MD (UNAH, 2011). Neurosurgeon (HUMV, 2017). Carlos Velásquez is a López-Albo Grant recipient (IDIVAL, 2017) and a Clinical Fellow in Neuro-oncology and Skull Base at the University of Toronto (2018-2019). He underwent further training in neuro-oncology research at Zadeh´s Lab (Princess Margaret Cancer Center, 2017-2018) and he is a current member of the "Cell Signalling and Therapeutic Targets in Cancer" research group at IDIVAL. García-Palomo Award recipient (HUMV, 2017). Member of the Spanish Society of Neurosurgery (SENEC) and the European Association of Neurosurgical Societies (EANS). Currently working on clinical and translational research in neuro-oncology and functional neuroanatomy. |
- Tumor heterogeneity in glioblastoma: An integrative approach
James S. Mc Donnell Foundation (USA) (2015 - 2016)
MD (UNAH, 2011). Neurosurgeon (HUMV, 2017). Carlos Velásquez is a López-Albo Grant recipient (IDIVAL, 2017) and a Clinical Fellow in Neuro-oncology and Skull Base at the University of Toronto (2018-2019). He underwent further training in neuro-oncology research at Zadeh´s Lab (Princess Margaret Cancer Center, 2017-2018) and he is a current member of the "Cell Signalling and Therapeutic Targets in Cancer" research group at IDIVAL. García-Palomo Award recipient (HUMV, 2017). Member of the Spanish Society of Neurosurgery (SENEC) and the European Association of Neurosurgical Societies (EANS). Currently working on clinical and translational research in neuro-oncology and functional neuroanatomy. |
- Tumor heterogeneity in glioblastoma: An integrative approach
James S. Mc Donnell Foundation (USA) (2015 - 2016)